News

Regeneron expands US manufacturing with $3B Fujifilm partnership
This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily ...
FujiFilm lands $3B manufacturing deal with Regeneron in Holly Springs
FujiFilm Diosynth plans to produce Regeneron's biologic medicines over 10 years in its Holly Springs facility, which is ...
Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted earnings per share of $8.22, down 14% ...
GEN - Genetic Engineering and Biotechnology News6d
FUJIFILM Diosynth Biotechnologies and Regeneron Sign 10-year, $3+ Billion U.S. Manufacturing Deal
FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.
Fierce Pharma5d
Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal
AstraZeneca and Daiichi Sankyo are gunning to get Enhertu a new first-line approval in HER2-positive breast cancer after a ...
NC Biotech6d
Corporate recombinations include $50M, new life for Durham’s Pelthos
Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...
Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus
Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...